Follow
Paolo Petazzi
Paolo Petazzi
Integra TX
Verified email at integra-tx.com
Title
Cited by
Cited by
Year
Dysregulation of the long non-coding RNA transcriptome in a Rett syndrome mouse model
P Petazzi, J Sandoval, K Szczesna, OC Jorge, L Roa, S Sayols, A Gomez, ...
RNA biology 10 (7), 1197-1203, 2013
852013
Altered expression of the imprinted transcription factor PLAGL1 deregulates a network of genes in the human IUGR placenta
I Iglesias-Platas, A Martin-Trujillo, P Petazzi, A Guillaumet-Adkins, ...
Human molecular genetics 23 (23), 6275-6285, 2014
842014
In vivo CRISPR/Cas9 targeting of fusion oncogenes for selective elimination of cancer cells
M Martinez-Lage, R Torres-Ruiz, P Puig-Serra, P Moreno-Gaona, ...
Nature communications 11 (1), 5060, 2020
832020
Mutations in JMJD1C are involved in Rett syndrome and intellectual disability
MA Sáez, J Fernández-Rodríguez, C Moutinho, JV Sanchez-Mut, ...
Genetics in Medicine 18 (4), 378-385, 2016
552016
Inhibition of Gsk3b reduces Nfkb1 signaling and rescues synaptic activity to improve the Rett syndrome phenotype in Mecp2-knockout mice
OC Jorge-Torres, K Szczesna, L Roa, C Casal, L Gonzalez-Somermeyer, ...
Cell Reports 23 (6), 1665-1677, 2018
452018
Improvement of the rett syndrome phenotype in a mecp2 mouse model upon treatment with levodopa and a dopa-decarboxylase inhibitor
K Szczesna, O De La Caridad, P Petazzi, M Soler, L Roa, MA Saez, ...
Neuropsychopharmacology 39 (12), 2846-2856, 2014
342014
Circadian cycle-dependent MeCP2 and brain chromatin changes
A Martinez de Paz, JV Sanchez-Mut, M Samitier-Martí, P Petazzi, M Sáez, ...
PloS one 10 (4), e0123693, 2015
332015
An increase in MECP2 dosage impairs neural tube formation
P Petazzi, N Akizu, A García, C Estarás, AM de Paz, ...
Neurobiology of Disease 67, 49-56, 2014
282014
A novel and efficient tandem CD19-and CD22-directed CAR for B cell ALL
SR Zanetti, T Velasco-Hernandez, F Gutierrez-Agüera, VM Díaz, ...
Molecular Therapy 30 (2), 550-563, 2022
272022
Profiling of oxBS-450K 5-hydroxymethylcytosine in human placenta and brain reveals enrichment at imprinted loci
JR Hernandez Mora, M Sanchez-Delgado, P Petazzi, S Moran, M Esteller, ...
Epigenetics 13 (2), 182-191, 2018
262018
Generation and characterization of rat and mouse monoclonal antibodies specific for MeCP2 and their use in X-inactivation studies
KL Jost, A Rottach, M Milden, B Bertulat, A Becker, P Wolf, J Sandoval, ...
PloS one 6 (11), e26499, 2011
252011
Pharmacological modulation of CXCR4 cooperates with BET bromodomain inhibition in diffuse large B-cell lymphoma
C Recasens-Zorzo, T Cardesa-Salzmann, P Petazzi, L Ros-Blanco, ...
haematologica 104 (4), 778, 2019
232019
Nitric oxide control of proliferation in nerve cells and in tumor cells of nervous origin
E Pena-Altamira, P Petazzi, A Contestabile
Current pharmaceutical design 16 (4), 440-450, 2010
232010
Integrative methylome-transcriptome analysis unravels cancer cell vulnerabilities in infant MLL-rearranged B cell acute lymphoblastic leukemia
JR Tejedor, C Bueno, M Vinyoles, P Petazzi, A Agraz-Doblas, I Cobo, ...
The Journal of Clinical Investigation 131 (13), 2021
142021
Generation of cholinergic and dopaminergic interneurons from human pluripotent stem cells as a relevant tool for in vitro modeling of neurological disorders pathology and therapy
A Ochalek, K Szczesna, P Petazzi, J Kobolak, A Dinnyes
Stem Cells International 2016, 2016
142016
Robustness of catalytically dead Cas9 activators in human pluripotent and mesenchymal stem cells
P Petazzi, R Torres-Ruiz, A Fidanza, H Roca-Ho, F Gutierrez-Agüera, ...
Molecular Therapy-Nucleic Acids 20, 196-204, 2020
122020
The hypomethylation of imprinted genes in IVF/ICSI placenta samples is associated with concomitant changes in histone modifications
C Choux, P Petazzi, M Sanchez-Delgado, JR Hernandez Mora, ...
Epigenetics 15 (12), 1386-1395, 2020
102020
CRISPR/Cas9–mediated gene knockout and knockin human iPSCs
P Petazzi, P Menéndez, A Sevilla
Induced Pluripotent Stem (iPS) Cells: Methods and Protocols, 559-574, 2020
92020
Efficient elimination of primary B-ALL cells in vitro and in vivo using a novel 4-1BB-based CAR targeting a membrane-distal CD22 epitope
T Velasco-Hernandez, SR Zanetti, H Roca-Ho, F Gutierrez-Aguera, ...
Journal for immunotherapy of cancer 8 (2), 2020
92020
ABO gene editing for the conversion of blood type A to universal type O in Rhnull donor‐derived human‐induced pluripotent stem cells
P Petazzi, L Miquel‐Serra, S Huertas, C González, N Boto, E Muñiz‐Diaz, ...
Clinical and Translational Medicine 12 (10), e1063, 2022
52022
The system can't perform the operation now. Try again later.
Articles 1–20